How common is Diffuse Large B-Cell Lymphoma?
Diffuse Large B-Cell Lymphoma is the most common type of non-Hodgkin’s lymphoma and represents about 35% of all cases. What is his prognosis? Most patients with this particular form and stage of non-Hodgkin’s lymphoma respond well to chemotherapy and radiation. Five-year survival rates are around 90%. How will this illness affect his ability to manage and lead the University? Most patients who receive this course of treatment are able to continue to work throughout the therapy. We expect that Mr. Seligman will as well, although he will be encouraged to slow down and get plenty of rest to maintain his strength. —Richard Fisher, M.D.
